Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ)
CNY 4.26
(-3.4%)
CNY 4.26
(-3.4%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 580.71 Million CNY | 39.12% |
| 2022 | 417.42 Million CNY | -40.48% |
| 2021 | 701.34 Million CNY | -44.29% |
| 2020 | 1.25 Billion CNY | -2.41% |
| 2019 | 1.29 Billion CNY | 2.59% |
| 2018 | 1.25 Billion CNY | -5.58% |
| 2017 | 1.33 Billion CNY | 71.34% |
| 2016 | 777.32 Million CNY | 393.43% |
| 2015 | 157.53 Million CNY | -51.0% |
| 2014 | 321.47 Million CNY | 60.64% |
| 2013 | 200.12 Million CNY | -27.88% |
| 2012 | 277.49 Million CNY | -10.82% |
| 2011 | 311.17 Million CNY | 8.62% |
| 2010 | 286.47 Million CNY | -15.85% |
| 2009 | 340.42 Million CNY | 8.51% |
| 2008 | 313.74 Million CNY | 0.45% |
| 2007 | 312.34 Million CNY | -9.09% |
| 2006 | 343.58 Million CNY | 0.69% |
| 2005 | 341.23 Million CNY | 21.73% |
| 2004 | 280.32 Million CNY | 37.51% |
| 2003 | 203.84 Million CNY | 794.43% |
| 2002 | -29.35 Million CNY | 73.83% |
| 2001 | -112.16 Million CNY | -332.36% |
| 2000 | -25.94 Million CNY | 76.19% |
| 1999 | -108.96 Million CNY | 47.88% |
| 1998 | -209.05 Million CNY | -1767.62% |
| 1997 | 12.53 Million CNY | 250.71% |
| 1996 | 3.57 Million CNY | -56.94% |
| 1995 | 8.3 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 546.12 Million CNY | -53.0% |
| 2024 Q1 | 914.2 Million CNY | 57.43% |
| 2024 Q2 | 571.84 Million CNY | -37.45% |
| 2023 Q4 | 580.71 Million CNY | 42.54% |
| 2023 Q3 | 407.4 Million CNY | -4.6% |
| 2023 Q2 | 427.04 Million CNY | 2.83% |
| 2023 FY | 580.71 Million CNY | 39.12% |
| 2023 Q1 | 415.27 Million CNY | -0.52% |
| 2022 Q3 | 519.06 Million CNY | -12.99% |
| 2022 Q4 | 417.42 Million CNY | -19.58% |
| 2022 FY | 417.42 Million CNY | -40.48% |
| 2022 Q1 | 636.2 Million CNY | -9.29% |
| 2022 Q2 | 596.56 Million CNY | -6.23% |
| 2021 Q4 | 701.34 Million CNY | -36.35% |
| 2021 Q1 | 1.17 Billion CNY | -6.33% |
| 2021 FY | 701.34 Million CNY | -44.29% |
| 2021 Q2 | 1.13 Billion CNY | -3.9% |
| 2021 Q3 | 1.1 Billion CNY | -2.76% |
| 2020 Q3 | 1.2 Billion CNY | -5.59% |
| 2020 Q1 | 1.46 Billion CNY | 13.55% |
| 2020 Q2 | 1.27 Billion CNY | -13.06% |
| 2020 Q4 | 1.25 Billion CNY | 4.71% |
| 2020 FY | 1.25 Billion CNY | -2.41% |
| 2019 Q3 | 1.19 Billion CNY | 17.61% |
| 2019 Q1 | 1.26 Billion CNY | 0.88% |
| 2019 FY | 1.29 Billion CNY | 2.59% |
| 2019 Q4 | 1.29 Billion CNY | 7.67% |
| 2019 Q2 | 1.01 Billion CNY | -19.7% |
| 2018 Q4 | 1.25 Billion CNY | 0.14% |
| 2018 FY | 1.25 Billion CNY | -5.58% |
| 2018 Q2 | 1.14 Billion CNY | -12.62% |
| 2018 Q1 | 1.3 Billion CNY | -1.99% |
| 2018 Q3 | 1.25 Billion CNY | 10.1% |
| 2017 Q2 | 1.1 Billion CNY | -13.58% |
| 2017 Q1 | 1.27 Billion CNY | 64.27% |
| 2017 FY | 1.33 Billion CNY | 71.34% |
| 2017 Q4 | 1.33 Billion CNY | -12.3% |
| 2017 Q3 | 1.51 Billion CNY | 37.61% |
| 2016 Q1 | 491.25 Million CNY | 211.83% |
| 2016 Q3 | 707.48 Million CNY | 21.21% |
| 2016 Q2 | 583.67 Million CNY | 18.81% |
| 2016 Q4 | 777.32 Million CNY | 9.87% |
| 2016 FY | 777.32 Million CNY | 393.43% |
| 2015 Q1 | -271.97 Million CNY | -184.6% |
| 2015 Q3 | 228.12 Million CNY | 673.53% |
| 2015 FY | 157.53 Million CNY | -51.0% |
| 2015 Q2 | -39.77 Million CNY | 85.37% |
| 2015 Q4 | 157.53 Million CNY | -30.94% |
| 2014 FY | 321.47 Million CNY | 60.64% |
| 2014 Q1 | 216.53 Million CNY | 8.2% |
| 2014 Q2 | 224.6 Million CNY | 3.73% |
| 2014 Q3 | 235.7 Million CNY | 4.94% |
| 2014 Q4 | 321.47 Million CNY | 36.39% |
| 2013 Q3 | 274.1 Million CNY | 1.14% |
| 2013 Q1 | 262.99 Million CNY | -5.23% |
| 2013 Q2 | 271.02 Million CNY | 3.05% |
| 2013 Q4 | 200.12 Million CNY | -26.99% |
| 2013 FY | 200.12 Million CNY | -27.88% |
| 2012 FY | 277.49 Million CNY | -10.82% |
| 2012 Q4 | 277.49 Million CNY | -1.27% |
| 2012 Q3 | 281.07 Million CNY | 0.6% |
| 2012 Q2 | 279.4 Million CNY | -11.8% |
| 2012 Q1 | 316.79 Million CNY | 1.81% |
| 2011 FY | 311.17 Million CNY | 8.62% |
| 2011 Q1 | 292.83 Million CNY | 2.22% |
| 2011 Q2 | 298.88 Million CNY | 2.07% |
| 2011 Q4 | 311.17 Million CNY | -0.3% |
| 2011 Q3 | 312.1 Million CNY | 4.42% |
| 2010 Q3 | 307.29 Million CNY | -9.44% |
| 2010 FY | 286.47 Million CNY | -15.85% |
| 2010 Q4 | 286.47 Million CNY | -6.78% |
| 2010 Q2 | 339.34 Million CNY | -2.79% |
| 2010 Q1 | 349.07 Million CNY | 2.54% |
| 2009 Q3 | 350.08 Million CNY | -1.45% |
| 2009 FY | 340.42 Million CNY | 8.51% |
| 2009 Q4 | 340.42 Million CNY | -2.76% |
| 2009 Q1 | 339.17 Million CNY | 8.11% |
| 2009 Q2 | 355.23 Million CNY | 4.74% |
| 2008 Q3 | 370.26 Million CNY | 0.96% |
| 2008 FY | 313.74 Million CNY | 0.45% |
| 2008 Q1 | 309.39 Million CNY | -0.95% |
| 2008 Q2 | 366.73 Million CNY | 18.53% |
| 2008 Q4 | 313.74 Million CNY | -15.26% |
| 2007 Q3 | 252.95 Million CNY | -19.16% |
| 2007 Q2 | 312.88 Million CNY | 0.64% |
| 2007 Q4 | 312.34 Million CNY | 23.48% |
| 2007 FY | 312.34 Million CNY | -9.09% |
| 2007 Q1 | 310.9 Million CNY | -9.51% |
| 2006 Q3 | 346.39 Million CNY | -2.86% |
| 2006 Q1 | 339.4 Million CNY | -0.54% |
| 2006 FY | 343.58 Million CNY | 0.69% |
| 2006 Q4 | 343.58 Million CNY | -0.81% |
| 2006 Q2 | 356.57 Million CNY | 5.06% |
| 2005 Q4 | 341.23 Million CNY | -0.29% |
| 2005 Q3 | 342.21 Million CNY | 6.09% |
| 2005 Q2 | 322.58 Million CNY | 4.17% |
| 2005 Q1 | 309.67 Million CNY | 10.47% |
| 2005 FY | 341.23 Million CNY | 21.73% |
| 2004 Q3 | -20.98 Million CNY | 42.03% |
| 2004 Q1 | -38.89 Million CNY | -119.08% |
| 2004 FY | 280.32 Million CNY | 37.51% |
| 2004 Q2 | -36.2 Million CNY | 6.91% |
| 2004 Q4 | 280.32 Million CNY | 1435.67% |
| 2003 Q3 | - CNY | -100.0% |
| 2003 Q2 | 13.59 Million CNY | 0.0% |
| 2003 FY | 203.84 Million CNY | 794.43% |
| 2003 Q4 | 203.84 Million CNY | 0.0% |
| 2003 Q1 | - CNY | 100.0% |
| 2002 Q2 | -62.11 Million CNY | 17.02% |
| 2002 FY | -29.35 Million CNY | 73.83% |
| 2002 Q1 | -74.85 Million CNY | 33.26% |
| 2002 Q3 | -33.36 Million CNY | 46.29% |
| 2002 Q4 | -29.35 Million CNY | 12.02% |
| 2001 FY | -112.16 Million CNY | -332.36% |
| 2001 Q4 | -112.16 Million CNY | 0.0% |
| 2001 Q2 | -70.62 Million CNY | 0.0% |
| 2000 Q4 | -25.94 Million CNY | 0.0% |
| 2000 FY | -25.94 Million CNY | 76.19% |
| 2000 Q2 | -100.58 Million CNY | 0.0% |
| 1999 Q2 | -143.06 Million CNY | 0.0% |
| 1999 FY | -108.96 Million CNY | 47.88% |
| 1999 Q4 | -108.96 Million CNY | 0.0% |
| 1998 FY | -209.05 Million CNY | -1767.62% |
| 1998 Q4 | -209.05 Million CNY | 0.0% |
| 1997 FY | 12.53 Million CNY | 250.71% |
| 1996 FY | 3.57 Million CNY | -56.94% |
| 1995 FY | 8.3 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 935.92 Million CNY | 37.953% |
| Zhejiang Zhenyuan Share Co., Ltd. | -320.75 Million CNY | 281.044% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 520.61 Million CNY | -11.544% |
| Yifan Pharmaceutical Co., Ltd. | 1.29 Billion CNY | 55.22% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | -129.14 Million CNY | 549.675% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.88 Billion CNY | 79.84% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -562.43 Million CNY | 203.25% |
| Boai NKY Medical Holdings Ltd. | -230.36 Million CNY | 352.083% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | -1.1 Billion CNY | 152.367% |